SME Support to Evaluate Innovative Medical Technologies: Round 2

Funding opportunity:

SME Support to Evaluate Innovative Medical Technologies: Round 2

Status:

Closed

Funder:

Office for Life Sciences (OLS) and Innovate UK

Project total costs (range):

£ 50,000 – £ 250,000

Opens:

02/07/2018

Competition closes:

22/08/2018 (12:00 noon)

The Office for Life Sciences (OLS) is partnering with Innovate UK, as part of UK Research and Innovation, to invest up to £1.5 million. This is to support developers of innovative medicines, medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.

This competition aims to provide support for small and medium-sized enterprises (SMEs). OLS and Innovate UK are looking for an evidence base that can evaluate products that address NHS priorities. The support provided will allow companies to collect and analyse clinical performance and cost effectiveness data in an NHS setting.

There are 2 options for applicants in this competition:

  1. Study planning and preparation. Total project costs up to £50,000.
  2. Collection of clinical performance and cost-effectiveness data study. Total project costs up to £250,000.

All projects must be business led.

Projects can be collaborative but this is not mandatory. Only the lead partner can claim grant.

Projects must start by 1 January 2019 and be completed by the end of December 2019.

MSC R&D can help your business develop by supporting you in:
• Identification of appropriate grants and competition calls for proposals
• Partner search for collaborative Research & Innovation
• Bid writing
• Project management
• Audit compliance
• Commercialisation
• Business Planning
• Market Intelligence reports

If you want help with any of these opportunities, please CONTACT us on 0114 230 8401 or email businessdevelopment@mscbdg.co.uk